Pfizer Abandons $350M Plant in Everett After Seagen Acquisition
New York City-based pharmaceutical giant Pfizer Inc. has stopped its $350 million manufacturing plant project in Everett, marking a pivot in the company’s strategic expansion after its $43 billion acquisition of Bothell-based Seagen. The Everett facility, located at 215 Shuksan…